Want to join the conversation?
$KORS 1Q16 PR: Total revenue increased 7.3% to $986MM from $919.2MM in 1Q15. On a constant currency basis, total revenue increased 13.4%. Net income was $174.4M or $0.87 per diluted share compared to $187.7MM or $0.91 per diluted share in 1Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.